Advertisement

U.S. markets closed

S&P Futures
4,218.25
+8.25(+0.20%)
Dow Futures
33,338.00
+78.00(+0.23%)
Nasdaq Futures
13,430.00
+38.00(+0.28%)
Russell 2000 Futures
1,974.00
+4.50(+0.23%)
Crude Oil
91.67
-0.26(-0.28%)
Gold
1,800.30
-13.40(-0.74%)

Advertisement

First Wave BioPharma, Inc. (FWBI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

0.1575

+0.0063

(+4.17%)

At close: 04:00PM EDT

0.1589

+0.00

(+0.89%)

After hours:

07:48PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	0.1512
Open	0.1513
Bid	0.1550 x 1100
Ask	0.1589 x 1300
Day's Range	0.1513 - 0.1575
52 Week Range	0.1350 - 8.5700
Volume	2,297,892
Avg. Volume	3,130,609

Market Cap	6.55M
Beta (5Y Monthly)	1.74
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FWBI

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

First Wave BioPharma, Inc.
Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
Rating
Fair Value
Economic Moat
3 days agoMorningstar